VC firm
Illumina Ventures
Also known as Illumina Innovation, Illumina Innovation Fund I, L.P., Illumina Innovation Fund II, L.P., Illumina Innovation Fund III, L.P.
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- FOSTER CITY, CA, United States
- Assets under management
- $643MForm ADV private fund GAV, as of 2026-03-31Source (opens in a new tab)
- Latest fund size
- $121MSEC amount sold, as of 2019Source (opens in a new tab)
- Funds
- 4
- Legal name
- IIF MANAGEMENT COMPANY, LLC
Claim, correct or request removal
Record updated 29 September 2026
About
Illumina Ventures is the leader in genomics and precision health investing. We are building the ecosystem and translating investment into innovation as we accelerate the impact on human health.
Investment approach
- Thesis
- Independently managed, we bring depth of knowledge, decades of domain expertise, strong operating experience, and a strategic relationship with Illumina (NASDAQ: ILMN). This enables us to identify and build companies that will transform healthcare and our world. We operate as true partners to entrepreneurs developing breakthrough science and technology into market-leading companies. Through Illumina Ventures Labs, we accelerate value creation for early-stage genomics start-ups via access to capital, sequencing, mentorship, and fully equipped genomics lab capabilities.Source (opens in a new tab)
Funds
- Illumina Innovation Fund III, L.P.
- $60MVintage 2023, SPV, SEC amount sold
- Illumina Innovation Fund II, L.P.
- $121MVintage 2019, Main fund, SEC amount sold
- Illumina Innovation Fund I, L.P.
- $189MVintage 2015, Main fund, SEC amount sold
- ILLUMINA INNOVATION FUND III, L.P.
- Main fund
SEC registration
- Registered adviser
- IIF MANAGEMENT COMPANY, LLC
- CRD number
- 283782 (opens in a new tab)
- SEC file number
- 802-107904
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $643Mas of 2026-03-31
- Private funds reported
- 3
- Principal office
- FOSTER CITY, CA, United States
- SEC CIK
- 1669427, 1779218, 2032562
Loading relationship preview